Clinical Trial

Blood-based Biomarkers for Alzheimer's Disease at the Primary Care Level.

Name: Blood-based Biomarkers for Alzheimer's Disease at the Primary Care Level. — clinical trial record (NCT07666113)
Creator: DataLookout
License: https://creativecommons.org/licenses/by/4.0/

Study acronym: ADPriK

Recruiting

View on ClinicalTrials.gov →

Summary

The goal of this study is to determine how blood biomarker tests (ptau217 and ptau217/Aβ42) performed in primary care influence the patient trajectory in individuals with cognitive concerns. Participants will provide a blood sample for biomarker testing and undergo clinical assessments as part of diagnostic evaluation.

Trial Details

NCT Number	NCT07666113
Lead Sponsor	Universitaire Ziekenhuizen KU Leuven
Conditions	Alzheimer's Disease (AD)
Enrollment	240 participants
Start Date	2026-05-26
Primary Completion	2030-04 (estimated)
Study Completion	2038-04 (estimated)
Updated on ClinicalTrials.gov	2026-06-24